Patient P-02056
Synthetic patientMETA-24 · Day 179 · 25–34 · F · baseline S10Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
9%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S10
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Treatment adherence+7
- Inflammatory activity+4
- Toxicity+2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable112 min
stable · +0.6 vs previous 14 d
Sleep duration
Wearable8.2 h
stable · -0.1 vs previous 14 d
Energy level
Daily log7.3/10
stable · -0.2 vs previous 14 d
Steps
Wearable11,364
stable · +156 vs previous 14 d
GI burden
Companion12.2/100
stable · +0.4 vs previous 14 d
Adherence
Companion93.7 %
improving · +4.0 vs previous 14 d
Sleep quality
Wearable73.7/100
stable · -1.1 vs previous 14 d
Glucose, CGM daily mean
CGM130 mg/dL
stable · +2.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 93 from the failing basin, 7 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -3.8 next day on high-intake days · n 17
Would not help
- Keep ultra-processed lowGI +1.9 next day on high-intake days · n 15
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.8supporter · 95%
- Simple carbohydrates-2no signal · 50%
- Ultra-processed food+1.9detractor · 58%
- Insoluble fibre+1.5no signal · 38%
- Dietary fat load-1.4no signal · 37%
- Alcohol+0.9no signal · 28%
- Histamine load-0.7no signal · 16%
- Caffeine+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Inflammatory signalling ↑25
- DNAIL6 -174 variant raises baseline inflammatory tone
DNA
Fictional pharmacogenomic panel
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Normal metabolizerExpected exposure
- GLP1R rs6923761 AAltered receptor sensitivity
Microbiome
Shannon diversity 3.1 · butyrate capacity 47/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 62 ms
- Sleep
- 8.0 h
- Steps
- 10,055
- Resting HR
- 72 bpm
Daily log: GI score 12, nutritional resilience 67, adherence 94.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02337 | 42% | S18 | DT-01 | no change | 100 |
| P-02249 | 38% | S09 | DT-01 | improved | 100 |
| P-02189 | 45% | S17 | — | — | 96 |
| P-02640 | 44% | S03 | — | — | 96 |
| P-02242 | 42% | S20 | — | — | 95 |
| P-02013 | 40% | S14 | BR-03 | no change | 94 |
| P-02104 | 42% | S15 | — | — | 94 |
| P-02450 | 45% | S12 | NP-02 | improved | 92 |
| P-02277 | 46% | S05 | AD-05 | improved | 92 |
| P-02304 | 35% | S15 | — | — | 92 |
| P-02653 | 39% | S14 | — | — | 91 |
| P-02689 | 36% | S13 | — | — | 91 |